Procurement and late-stage development of smallpox antiviral drug(s)
Active Definitive Contract Awarded Last action
- Contract number
- 75A50118C00019
- Awardee
-
Siga Technologies, Inc. UEI VJRNRTSL22K4
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $626,506,870
Award facts
- Opportunity
-
- Procurement and Late-Stage Development of Smallpox Antiviral Drug(s) Pre-Solicitation · 18100SOL00011 · Posted Feb 9, 2018
- Contract value 100% obligated
- $626,506,870.00 Current and potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Corvallis, OR, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $2,068,321 | |
| Funding Only Action | $13,172,832 | |
| Funding Only Action | $14,324,736 | |
| Exercise an Option | $25,625,600 | |
| Exercise an Option | $112,552,320 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $138,177,300 | |
| Exercise an Option | $29,212,406 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $112,551,700 | |
| Supplemental Agreement for work within scope | $15,360 | |
| Exercise an Option | $101,296,530 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $2,425,815 | |
| Funding Only Action | $11,255,170 | |
| Funding Only Action | $12,186,975 | |
| Original award | $51,641,805 |
Show all 22
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a $626.5 million definitive firm fixed-price contract to Siga Technologies, Inc. for procurement and late-stage development of smallpox antiviral drugs on September 10, 2018, with no set-aside.
Place of performance is Corvallis, OR. The originating pre-solicitation, posted February 9, 2018 with a due date of April 23, 2018, solicited IV smallpox antiviral procurement and development. The contract extends through August 30, 2029.
In FY2025, the contract generated $142.6 million in government-invoiced labor across 6.2 FTEs and 12,988 contractor hours, representing a year-over-year increase from FY2024's 4.6 FTEs and 9,660 hours. The derived government-paid hourly rate declined from $14,035.69 in FY2024 to $10,978.70 in FY2025. Siga Technologies executed the contract with three subcontractors as of FY2025.
Quick answers
Who was awarded contract 75A50118C00019?
75A50118C00019 was awarded to Siga Technologies, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 10, 2018.
How much is contract 75A50118C00019 worth?
The government has obligated $626,506,870 on 75A50118C00019.
Was contract 75A50118C00019 competed?
The extent of competition for 75A50118C00019 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award